[
    [
        {
            "time": "",
            "original_text": "医药生物行业周报:政策对情绪面影响大于基本面,基药、医保目录对接调整是关注重点",
            "features": {
                "keywords": [
                    "医药生物",
                    "政策",
                    "情绪面",
                    "基本面",
                    "基药",
                    "医保目录",
                    "对接调整"
                ],
                "sentiment_score": -0.2,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药生物行业周报:政策对情绪面影响大于基本面,基药、医保目录对接调整是关注重点",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]